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ABSTRACT
We performed ultra-deep methylation analysis at single molecule level of the promoter region of
developmentally regulated D-Aspartate oxidase (Ddo), as a model gene, during brain development and
embryonic stem cell neural differentiation. Single molecule methylation analysis enabled us to establish
the effective epiallele composition within mixed or pure brain cell populations. In this framework, an
epiallele is deﬁned as a speciﬁc combination of methylated CpG within Ddo locus and can represent the
epigenetic haplotype revealing a cell-to-cell methylation heterogeneity. Using this approach, we found a
high degree of polymorphism of methylated alleles (epipolymorphism) evolving in a remarkably
conserved fashion during brain development. The different sets of epialleles mark stage, brain areas, and
cell type and unravel the possible role of speciﬁc CpGs in favoring or inhibiting local methylation.
Undifferentiated embryonic stem cells showed non-organized distribution of epialleles that apparently
originated by stochastic methylation events on individual CpGs. Upon neural differentiation, despite
detecting no changes in average methylation, we observed that the epiallele distribution was profoundly
different, gradually shifting toward organized patterns speciﬁc to the glial or neuronal cell types. Our
ﬁndings provide a deep view of gene methylation heterogeneity in brain cell populations promising to
furnish innovative ways to unravel mechanisms underlying methylation patterns generation and
alteration in brain diseases.
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Introduction
Epigenetic proﬁles are sculpted during development; in par-
ticular, the DNA methylation landscape of mammalian
brain cells is dynamically reconﬁgured through develop-
ment.1-3 Such reconﬁguration occurs at brain speciﬁc genes
prevalently during the late stages of embryogenesis and
early post-natal developmental period, leading to critical
changes in the gene expression program that, once the pro-
cess comes to an end, is thought to be maintained through-
out life. A progressive shaping of DNA methylation
patterns occurs in a regulated manner, both at CpG and
CpH sites, during development and ﬁrst weeks or years of
life, possibly providing an epigenetic memory speciﬁc for
each type of brain cells.3 Such phenomenon, crucial to the
completion of embryonic development, is the result of a
dynamic interplay between DNA methylation and demeth-
ylation events assisted by different DNA methyltransferases
(DNMT1, DNMT3a, and DNMT3b), which may convert
cytosine to methylcytosine,4-7 or by Ten-11 translocation
enzymes (TETs), which promote 5mC demethylation.8 At
the genomic level, as a result of these processes, each type
of brain cells acquires a cell type-speciﬁc genomic DNA
methylation landscape that may provide an ‘identity card’
for different brain cells and govern and stabilize an elected
gene expression program. A recent study9 showed that dif-
ferent types of glial cells and neurons display very distinc-
tive methylation signatures, suggesting that the epigenomic
landscape reﬂects neuronal diversity. Appropriate patterns
of DNA methylation in the brain play an important role in
neurodevelopment and neuropsychiatric conditions,10-20
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pointing out to the importance of correct formation and
preservation of DNA methylation patterns in brain cells.
However, the vast majority of these studies, regardless of
the techniques employed, took in consideration the average
amount of CpG methylation in speciﬁc genomic regions or
their genome-wide distribution with only relative high reso-
lution. In principle, each cell may bear a speciﬁc combina-
tion of methylated CpGs at speciﬁc loci that may reﬂect the
origin of the cell and/or the functional state of a given gene
(allele) in that cell. This introduces the concept of “epipoly-
morphism,” which goes far beyond the simple identiﬁcation
of differentially methylated regions, by means that brain
cells may be considered a population of epigenetically het-
erogeneous cells in which each combination of methyl
CpGs at a given locus represents a speciﬁc epiallele. Such
information is lost when the average methylation, even at
single CpG sites, is evaluated. Using genome-wide
approaches, recent studies based on the comparison of the
methylation of few adjacent CpGs have addressed the issue
of heterogeneous methylation, accounting for cell-to-cell
methylation variability in liver,21 leukemias,22 and immor-
talized ﬁbroblasts,23 describing the stochastic and clonal
evolution of epialleles during carcinogenesis.
In this work, we investigated whether cell-to-cell methyla-
tion variability exists in brain and if this variability represents
the result of methylation and demethylation events occurring
stochastically at individual CpG sites or derives from a well
orchestrated process. In order to gain insight into this matter,
we performed ultra-deep methylation single molecule analysis
of a selected locus, the D-Aspartate oxidase (Ddo) gene,24,25 in
different brain developmental stages, areas, cell types, and
embryonic stem cells (ESCs) neural differentiation process. The
choice of Ddo as a model gene was mainly based on the facts
that this gene is developmentally regulated in brain by DNA
methylation changes,25 the average methylation levels range
between 60 and 30% in different stages, and the promoter is rel-
atively poor in CpG content,25 which we considered ideal con-
ditions to study variation of intermediate epiallele composition
at different times during development and in different brain
cell types.
Results
Epiallele analysis principles
Amplicon bisulﬁte sequencing of a given genomic region
enables us to determine whether each included CpG dinu-
cleotide, in each single molecule, is methylated or unmethy-
lated. Upon high-coverage bisulﬁte sequencing, it is possible
to determine, with high precision, either the average meth-
ylation at each CpG site or the asset of methylated and
unmethylated CpG sites present in each amplicon-derived
sequence. As an example, a region that includes 4 CpG sites
may give origin to 16 possible combinations that may be
potentially found in a mixed population of cells (Fig. 1).
These different combinations will be here referred to as
“epialleles;” the number of different exhibited epialleles pro-
vides a measure of the level of “epipolymorphism” (see
Fig. 1 for details and examples). We applied this kind of
methylation analysis to investigate the epiallele combina-
tions and evolution of the Ddo gene, as example of a locus
undergoing methylation changes during brain
development.25
Averaged methylation and epiallele frequency distribution
analysis of a 3 kb region in the Ddo gene in whole brain
during development
Using mouse brain at stages embryonic day 15 (E15), post-natal
day 0 (P0), and post-natal day 30 (P30), we performed high-
coverage targeted bisulﬁte sequencing including 7
amplicons (R1-R7) covering an extended large genomic region
(about 3 kb) surrounding the Ddo transcriptional start site
(TSS) (Fig. 2A). Primers used in this study are reported in
Table 1. Note that we previously reported averaged quantitative
methylation data for regions R4 and R5,25 which we have here
integrated into Fig. 2B in order to provide a comprehensive
view of averaged methylation changes at the extended Ddo
locus. Then, we performed single molecule analysis of the R4
region by determination of epiallele frequency (Fig. 3A). Sixty-
four (26) possible epialleles were expected. Fig. 3B shows the
results from the analysis of whole brains (n D 3) at E15 stage.
Several interesting aspects were worth of note. First, we found,
with different frequencies, the occurrence of almost all the the-
oretically predicted epialleles. At E15, fully methylated mole-
cules represented about 13% (the average methylation for each
site was evaluated at about 56%), the unmethylated molecules
totaled about 10%, while the remaining 77% of the cells har-
bored one of the 62 intermediate epialleles, which, although
with different frequencies, were all represented in the brain cell
mixture. However, we observed that some speciﬁc epialleles
were represented with higher than expected frequency. Such
frequency distribution was strikingly conserved among individ-
uals. These ﬁndings highlighted either a high degree of epipoly-
morphism of the Ddo promoter in the brain or a high
interindividual conservation of epiallele frequency distribution.
The interindividual conservation of epialleles patterns
was strikingly retained in brains at each of the analyzed
developmental stages from E15 to P30 (0.786  Pearson
R  0.992, P < 0.001) (Fig. 4, Table 2). Simulation
approach conﬁrmed the non-randomness of the observed
epialleles distribution showing a consistent deviation from
the simulated frequency for each of the epialleles (Supple-
mental Fig. S1). Thus, the observed phenomenon appears to
be a consequence of a precise mechanism governing the for-
mation and maintenance of predetermined methylation pro-
ﬁles in each of the different brain cells. The same analyses
were performed on other regions of the Ddo gene (R1-R7).
Although each of the analyzed regions showed variable
numbers of CpGs and different methylation averages (rang-
ing from 96 to 20%) and variation over developmental
stages, the data clearly conﬁrmed the existence of a strong
interindividual conservation for all the regions (Supplemen-
tal Fig. S2 and data not shown). However, lower epiallele
polymorphism and no changes over time were observed in
the upstream regions R1 and R2, as expected by the con-
stant high rate of average methylation in these regions
(85–95%) (Supplemental Fig. S2).
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Different brain areas display distinct epiallele
conﬁgurations
The eventuality that distinctive epiallele patterns were recog-
nizable in different brain areas was investigated. Methylation
average and epiallele frequency were analyzed in hippocam-
pus, cortex, prefrontal cortex (PFC), cerebellum, and striatum
at R4 in the Ddo promoter region. By averaged methylation
analysis the highest methylation levels (about 50%) were
observed in striatum (Fig. 5A and Fig. 5B). Conversely, in hip-
pocampus, the lowest methylation level (about 15%) was pres-
ent. Cerebellum, cortex, and PFC showed intermediate levels
(about 20–25%) that resembled those observed in whole
brain. We analyzed the frequency of intermediate epialleles
Figure 1. Principle of epipolymorphism and epiallele analysis. Averaged methylation degree, even at single base resolution, does not give any information on cell-to-cell
methylation variability. In the example reported in the Figure, which shows analysis of 4 adjacent CpG sites, 50% methylation degree may correspond to completely dif-
ferent methylation scenarios. These range from the lowest degree of epipolymorphism (bottom left) to the highest level (bottom right). However, reliable analysis of the
relative frequency of each epiallele must rely on a high number of analyzed sequences. Compared to genomic approaches previously used to measure the general epipo-
lymorphism degree, the here adopted amplicon bisulﬁte sequencing, although limited to targeted genomic regions, allowed us to magnify the details of cell-to-cell epial-
lele variability at single loci, thanks of the very high sequencing coverage (about 210,000 in this study) and to comprehensively establish the methylation pattern of
several adjacent CpG sites of longer regions (up to 600–1000 bp) in which all CpGs within individual reads are effectively phased and may represent the epigenetic haplo-
type. TSS: transcription start site. The pie charts represent the percentage of fully unmethylated epialleles (U D white), fully methylated epialleles (F D black), and the 62
remaining possible methyl CpG combination or intermediate epialleles (I D gray gradient).
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and observed high epiallele heterogeneity within each area
(Fig. 5C). Interestingly, although the proﬁles were clearly dis-
tinguishable among the different brain areas, these mainly dif-
fered in the relative abundance of a few major preferential
CpG combinations (see peaks in the bottom graph in
Fig. 5C). Moreover, it is worth noting that even in highly
methylated striatum (average methylation level of about
50%), more than 30% of the cells bear fully unmethylated
alleles, against 18% of cells bearing fully methylated ones.
Speciﬁc epiallele patterns distinguish different puriﬁed
brain cell populations
The high degree of epipolymorphism found both in total
brain and separated brain areas could be potentially
explained by cellular heterogeneity. Therefore, we decided
to investigate whether different puriﬁed brain cells, namely
neurons, oligodendrocytes, astrocytes, and microglial cells,
displayed cell type-speciﬁc methylation features. First, we
performed quantitative methylation analysis and showed
that different cell types exhibited different average methyla-
tion degree, with astrocytes being the less methylated and
microglial cells the most methylated (Fig. 6A). Analysis of
epiallele frequency distribution indicated that, as was also
observed in separated brain areas, that higher average meth-
ylation levels were associated with higher percentage of
hypermethylated epihaplotypes [see, as an example, micro-
glia (green line) vs. astrocytes (purple line) in Fig. 6B].
Conversely, lower average methylation was associated with
higher frequency of speciﬁc mono- and di-methylated con-
formations. However, speciﬁc epialleles, although enriched
at different degrees, showed peaks that were clearly
coincident across cell types and, for the most part, also
with peaks observed in whole brain tissue samples (compare
Figs. 4 and 5). These observations again point to the exis-
tence of a hierarchy among epialleles that is highly con-
served across different brain derived cells. In summary, we
conﬁrmed that most of the methylation rules observed in
brain tissues applied also for isolated brain cells, including
the high percentage of intermediate epialleles, high degree
of epipolymorphism, and high conservation of epialleles fre-
quency among the same type of cells among individuals.
Our data strongly suggest that, within a cell population,
either in whole brain, separated brain areas, or isolated pri-
mary cells, the epiallele frequency distribution occurs in a
non-stochastic manner. In particular, we observed a spatial
speciﬁcity by means of some CpG sites (¡363, ¡330,
¡242) being prone and some (¡318, ¡125, ¡175) being
more resistant to methylation. However, in a subset of cells
for each lineage, in a proportion consistent with the level of
average methylation, methylation spread from susceptible
sites by recruiting nearby CpGs, increasing the number of
molecules in which resistant CpGs became methylated. In
the future, it would be particularly intriguing to explore the
potential contribution of epiallele distribution analysis to
the reliable evaluation of cell function and cell type-speciﬁc
enrichment in given areas, during lifetime and/or in patho-
logical conditions.
Primary vs. immortalized neuronal cells
Interestingly, when we analyzed epiallele frequencies in A1 cells,
c-myc immortalized neurons at different culture passages
(Fig. 6C), despite observing an average methylation similar to
the one observed in primary neurons (see Fig. 6A and pies in 6B
Figure 2. Quantitative methylation analysis of a 3 kb genomic region of Ddo gene. A) Structure of the putative mouse Ddo gene promoter. Blue arrow indicates the tran-
scription start site (C1). White box represents the putative regulatory upstream region. Black box represents exon 1. Gray box represents ﬁrst intron. Positions of CpG sites
are indicated as relative to TSS. The analyzed 3 kb genomic portion is divided in 7 regions (R1-R2-R3-R4-R5-R6-R7) corresponding to different amplicons. B) Graph repre-
sents methylation average at each CpG site analyzed by Illumina MiSeq Sequencer. Each color line represents the average of 3 mice at a given developmental stage.
Blue D E15; red D P0; green D P30. Error bars show standard deviations. For each CpG site, the points labeled with different letters on top are signiﬁcantly different
(P< 0.05) based on post-hoc ANOVA analysis (Tukey test, performed on each CpG site). Where two developmental times were considered, Student t test was applied with
P < 0.05, P < 0.01, P < 0.001.
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and 6C), an opposite methylation scenario was observed in terms
of epiallele frequency distribution. In fact, few epialleles were
highly prevalent, most were absent, and epiallele proﬁles were
discordant both among different plates (Pearson R D 0.083) and
when compared with those derived by primary cells. These data
suggest that immortalized neurons, by contrast with tissue and
primary cells, show lower epiallele heterogeneity (clonal-like
behavior) and a likely stochastic epiallele frequency distribution.
Figure 3. All possible methyl CpG combinations (epialleles) at the Ddo R4 region. A) Representation of all 64 theoretically possible epialleles at region R4 of Ddo promoter
containing 6 CpG sites. Circles represent the CpG sites analyzed (¡363, ¡330, ¡318, ¡242, ¡175, and ¡125); black circles D methylated CpG; white circles D unmethy-
lated CpG. B) Percent frequency of each epiallele in whole brain from 3 mice (M1, M2, and M3) at E15 stage.
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Dynamic remodeling of Ddo epiallele proﬁles in ESCs upon
induction of neural differentiation
Evolution of epiallele frequency distribution at the Ddo pro-
moter was then tracked in ESCs upon neural differentiation.
Although average methylation of the 6 CpG sites at the Ddo R4
region was almost identical in undifferentiated and differenti-
ated ESCs (Fig. 7A), and minor differences were observed at
single CpG sites (Fig. 7B), when analysis of epiallele frequency
distribution was applied we observed a striking and reproduc-
ible methylation drift in 3 independent experiments (Fig. 7C).
Undifferentiated ESCs displayed an apparently disorganized,
Figure 4. Epialleles frequency distribution at Ddo R4 region during different stages of mouse development (E15, P0, P14, P30). The pie charts represent the percentage of
unmethylated epialleles (UD white), fully methylated epialleles (FD black), and all 62 intermediate epialleles (ID gray gradient). The line graph shows the percentage of
each of the intermediate epialleles; each color line identiﬁes one mouse. Blue D mouse 1; red D mouse 2, green D mouse 3. At the bottom of the last graph, the speciﬁc
methyl CpG combinations of the 62 intermediate epialleles are reported. 1M identiﬁes the group of monomethylated molecules; 2MD dimethylated; 3MD trimethylated;
4M D tetramethylated; 5M D pentamethylated epialleles. Pearson correlation R reported in Table 2.
Table 1. List of primers used to amplify Ddo promoter regions (R1-R7) and the M13 mp18 control plasmid. For Ddo regions, the positions refer to TSS; for M13 mp18 the
positions refer to sequence entry X02513.1 (NCBI, GenBank).
GENE AMPLICON FW PRIMER RV PRIMER
Ddo R1 ¡2170/¡1960 TttggtttttattTtTaaatTTtgata AactAActatacatctcacttccctA
Ddo R2 ¡1578/¡1184 GgttagtggtttTtttgTagTTtttat AAcattAtcccttcaAtccacaat
Ddo R3 ¡927/¡499 GTttttTTaTatgtTttggagTTt acctccctAaaaAtcatttAattcta
Ddo R4 ¡468/¡63 GtgtgtttTtgaggaggtgaTaTtTa262 3 aActtaccctccattAAtccatAcc
Ddo R5 ¡229/C144 GgTtggtggTaagTtgaagttTttg acccctaaaatcccaAaAtAcatac
Ddo R6 C267/C671 TTtagtgttaaTttattagagTtgtgg AAtacaatcccttcttAcaacaAAca
Ddo R7 C801/C1201 GagggagttgggTatggagTaTaTata AactctaAAAaAcaAacacaAaAAtc
M13 mp18 5946 / 6294 Ggtgaagggtaattagttgttgtt ccaataccaaacttacatacct
The capital letters in the primers sequences indicate the original C or G.
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rather scattered, distribution of the possible 62 combinations,
with a slight prevalence of monomethylated molecules. Upon
neural differentiation toward neural cells, we observed a spe-
ciﬁc and highly reproducible rearrangement of the epiallele
frequency distribution proﬁle (Pearson R D 0.492, P < 0.001)
(Fig. 7C and Fig. 7D) that strongly supported the existence of a
programmed combinatorial code and a methylation drift
within the cell population. In particular, differentiated ESCs
showed sharp organized peaks corresponding to constant
enrichment of few speciﬁc intermediate epialleles and concom-
itant impoverishment of most of the others and their deriva-
tives (e.g., molecules containing methylated ¡242 and/or
¡125). Noticeably, 7 (out of 62) intermediate epialleles that
bloomed upon differentiation (¡330; ¡363; ¡330/¡318;
¡363/¡330; ¡363/¡330/¡318; 363/¡330/¡318/¡242, 363/
¡330/¡318/¡242/¡175) mostly corresponded to the major
peaks observed in developing whole brain as well as neurons
and glial cells, with different relative abundance. In fact, we
performed an analysis of the epigenetic correlation based
either on the type of displayed epialleles and on the relative
amount of each possible methyl CpG arrangement found in
each analyzed sample. This was performed by principal com-
ponent analysis (PCA). Results reported in Fig. 8A and Fig. 8B
conﬁrmed the reproducibility of the Ddo epigenetic drift
between undifferentiated and differentiated state and showed
that differentiated ESCs dramatically shifted toward mature
neural and glial patterns. Taken together, these data are com-
patible with a model in which in the undifferentiated state the
CpG methylability at the Ddo promoter mainly depends on the
primary sequence and occurs in a random manner at one or
more CpG sites. Conversely, in the differentiated state, possibly
due to newly generated structured chromatin conformation
constraints, a coordinated interplay between contiguous CpGs
differing in methylation susceptibility underlies speciﬁc epial-
lele frequency and dynamics in a spatial-speciﬁc manner,
where the methylated state of more susceptible sites (¡330 and
¡363) increases the likelihood that adjacent resistant sites
become methylated. These basic rules are then retained in the
mature glia and neurons. In support of this model, Fig. 8C
shows the relative contribution of each CpG to the formation
of different epialleles.
Discussion
In this study we have performed an ultra-deep methylation
analysis to study the methylation proﬁles of single genomic
regions (surrounding the Ddo gene) taking into account cell-
to-cell heterogeneity and quantifying the frequency of each
methylation pattern (epiallele) present in mixed and pure pop-
ulations of brain cells during development and neural differen-
tiation. The results substantiate well-appreciated general
phenomena: i) methylation is highly polymorphic and possibly
undergoes a continuous turnover; ii) such diversity is determin-
istic and not stochastic; and iii) the diversity converges in the
course of neural development. Furthermore, an epigenetic drift
at the Ddo gene, clearly appreciated in terms of epiallele proﬁles
and fully unpredictable by conventional methylation determi-
nation, marked ESCs neural differentiation process. Overall,
the ﬁndings support the hypothesis that the methylation state
of each CpG in single cells is not stable; rather, it is subject to
periodic ﬂuctuations. This appears to occur in a spatial-speciﬁc
manner, where the methylated state of more susceptible sites
(e.g., ¡330 and ¡363 in the R4 region) favors methylation of
adjacent otherwise partially resistant sites. These rules are
retained in mature brain where the differential average methyl-
ation in each cell type mainly derives from the relative percent-
age of fully methylated and unmethylated molecules and from
the relative abundance of speciﬁc peaks, within a prevalent
ﬁxed set of intermediate epialleles. Whether these rules may
apply to different genomic regions or are limited to some spe-
ciﬁc regions (e.g., CpG-poor promoter) remains to be deter-
mined. However, it is intriguing to hypothesize that speciﬁc
CpGs lying upstream the TSS may serve as a “core” and “seed”
by means that their methylation state may directly inﬂuence
the methylation state of the adjacent regions, giving origin, in a
continuous dynamic manner, to speciﬁc epiallele proﬁles distri-
butions. Although a limit of this approach is that it does not
allow the direct match of cell-by-cell methylation, mRNA
expression, and cell identity data, it may circumvent the difﬁ-
culties and high costs of single-cell analyses, with which it
shares the ability to address cell-to-cell methylation differences
and underlying mechanisms in a cell population. We have
recently developed a pipeline, namely amplimethprophiler
(https://sourceforge.net/projects/amplimethproﬁler), that ren-
ders such kind of analysis, performed at individual genomic
loci, easily approachable by other researchers interested in
applying these principles to any biological system and genomic
regions. To our knowledge, no study to date has addressed the
epiallele diversity in brain and in brain-derived cells. In the
recent past, very few studies ingeniously addressed cell-to-cell
methylation heterogeneity, prevalently in tumor systems and at
genome-wide level,22,23,26-30 supporting general rules that are
mostly consistent with the here presented data. Landan et al.23
suggested that a stochastic series of subtle and progressive
methylation changes in cancer evolution leads to deterministic
methylation proﬁles. Spatially speciﬁc methylation patterns
emerged, by means that some CpGs are particularly sensitive to
changes in methylation, creating an initiation point for methyl-
ation that then spreads over the region. Our data are compati-
ble with this model, according to which, in subsets of cells
within each population, methylation proﬁles take origin by the
Table 2. Relationship among the epialleles distribution within each stages group.
The analyses were performed by correlating mice of each developmental stage in
twos. Pearson's correlation coefﬁcient R and P-value are reported.
Pearson correlation test of epialleles distribution Ddo R4 region
STAGE Mice Pearson R P-value
E15 M1/M2 0.986067197 1.89637E–48
E15 M1/M3 0.992391755 2.71669E–56
E15 M2/M3 0.9868598 3.30893E–49
P0 M1/M2 0.959438583 1.08587E–34
P0 M1/M3 0.944346038 1.15656E–30
P0 M2/M3 0.88145423 3.27535E–21
P14 M1/M2 0.786309702 3.66001E–14
P14 M1/M3 0.846990179 4.13024E–18
P14 M2/M3 0.981271547 1.26582E–44
P30 M1/M2 0.833321788 4.37257E–17
P30 M1/M3 0.801413887 5.13155E–15
P30 M2/M3 0.984769846 2.69114E–47
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spreading from susceptible sites that, when methylated, become
able to inﬂuence nearby CpGs. Moreover, by the reanalysis of
reduced representation bisulﬁte sequencing (RRBS) data from
normal and cancerous tissues, Landan et al.23 also observed
that 2 methylation patterns of DNA molecules from the same
cell population were rather different from each other with
exception of H1 ESC and testis, which displayed coherent and
homogeneous methylation proﬁles. By contrast, in developing
brain and puriﬁed brain cells, we found a striking conservation
of epiallele proﬁles at the Ddo gene within the same type of
samples deriving from different mice. Moreover, we found that
in undifferentiated ESCs the methylation proﬁles were rather
Figure 5. Epiallele composition analysis of Ddo R4 in separated areas of mouse brain (Hipp: hippocampus; CB: cerebellum; CX: Cortex; ST: striatum; PFC: prefrontal cortex)
and in whole brain (WB) at P30 stage. A) Average methylation at the Ddo R4 region in each separated brain area. The bars labeled with different letters on top are signiﬁ-
cantly different based on post-hoc ANOVA statistical analysis (Tukey test). B) Average methylation at each CpG site (¡363, ¡330, ¡318, ¡242, ¡175, and ¡125). The
bars labeled with different letters on top are signiﬁcantly different based on post-hoc ANOVA analysis (Tukey test) performed for each CpG site. C) Ddo R4 region epiallele
frequency distribution. The pie charts represent the percentage of unmethylated epialleles (U D white); fully methylated epialleles (F D black); and all 62 intermediate
epialleles (I D gray gradient). Each color line represents the distribution of 62 intermediate epialleles in one brain area, as indicated. At the bottom of the graph, the spe-
ciﬁc methyl CpG combinations of each of the 62 intermediate epialleles are reported. A P-value  0.05 was considered statistically signiﬁcant.
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disorganized and highly polymorphic at the Ddo gene, shifting
toward an ordered, non-stochastic, and less polymorphic epial-
lele proﬁle upon induction of neural differentiation. These
apparent discrepancies may derive by the fact that our analysis
was based on a higher number of reads per locus and that it
was performed on CpG-poor gene regulatory region, while
CpG-rich regions are mostly considered, especially in RRBS-
based analyses, by genome-wide approaches. In a recent study,
Li et al.,22 using the methclone program, were able to map a
series of loci (“eloci”), consisting of 4 adjacent CpGs, subjected
to epigenetic drift during leukemia progression. This study,
based on combinatorial entropy as a measure of epiallele shift,
observed at single locus throughout the genome, revealed
enrichment of eloci in the genic region, in particular at pro-
moter regions, which is in line with our ﬁndings. Moreover, by
analyzing eloci during leukemia progression, the authors con-
cluded that the analysis of epiallele composition may reveal
clonal shifts at speciﬁc loci otherwise not detectable. In agree-
ment with this observation, we found that, upon differentiation
of ESCs, the Ddo promoter underwent a methylation shift, as
clearly detected by epiallele analysis, which was unpredictable
by traditional methylation analysis. However, previous studies
addressing epiallele composition were mostly performed in
tumor progression systems and, thus, epiallele changes were
interpreted as clonal shifts. In the future, it would be very inter-
esting to establish whether the epigenetic drift, here reported at
the Ddo gene during differentiation, is due to a clonal effect or,
rather and more likely, to a methylation remodeling occurring
in the ESC population upon induction to differentiate.
Although at this stage no association can be made between
each epihaplotype and functional state of the gene, it will be
important, in the near future, to establish how individual epiha-
plotypes impact gene expression.
In support of our data, a recent paper addressed the cell-
to-cell epivariation by single cell analysis concluding that
epivariation frequency in DNA methylation is at least 2
orders of magnitude higher than mutation frequency.31
Nevertheless, data on single cell analyses are rapidly accu-
mulating, including simultaneous methylome and transcrip-
tome determination on single cells.32 These efforts will
likely help us decipher the “epiallele code” that, in turn,
could be easily applied to take maximum advantage of, and
to interpret more in depth, the data obtained on single
genomic regions using the here proposed “affordable”
Figure 6. Averaged and single molecule methylation analysis of the Ddo promoter region in isolated primary brain cells and in cultured c-myc immortalized neurons.
A) Average methylation in different indicated brain cells. The bars labeled with different letters on top are signiﬁcantly different based on post-hoc ANOVA statistical anal-
ysis (Tukey test). B) Frequency distribution of intermediate epialleles in primary cells. C) Epiallele distribution in c-myc cultured immortalized neurons. Neuro: primary neu-
rons, blue bars in A and blue lines in B. Oligo: primary oligodendrocytes, red bars in A and red lines in B. Micro: primary microglial cells, green bars in A and green lines in
B. Astro: primary astrocytes cells, violet bars in A and violet lines in B. Neu C-Myc I and Neu C-Myc II: A1 C-Myc immortalized neurons, dark blue and orange, respectively,
in A (bars) and C (lines). The pie charts represent the percentage of unmethylated epialleles (U D white); fully methylated epialleles (F D black); and all 62 intermediate
epialleles (I D gray gradient). At the bottom of each graph, the speciﬁc methyl CpG combinations of each of the 62 intermediate epialleles are reported.
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comprehensive approach. The latter retains the unique
advantage to allow not only the description of heterogeneity
in a cell population but also the determination of whether
the heterogeneity is conserved among individuals.
Overall, our ﬁndings indicate that epiallele composition
dynamics in brain cell population are very ﬁnely tuned and
strikingly conserved. We suggest that tracking epiallele proﬁles
may help get insight into the mechanisms underlying DNA
Figure 7. Single molecule methylation analysis in ESC neural differentiation model. A) Averaged methylation at Ddo R4 region in undifferentiated ESCs (U-ES) and in dif-
ferentiated ESCs (nD-ES) from 3 independent experiments. B) Averaged methylation of each CpG site (¡363, ¡330, ¡318, ¡242, ¡175, and ¡125) at Ddo R4 region
(data are showed as mean § standard deviation; P < 0.01). C) Microscope images of ESCs in undifferentiated state (U-ES) and upon differentiation toward neuronal
phenotype (nD-ES). Bar D 200 mm. Epiallele frequency distribution in 3 independent ESCs differentiation experiments (I, II, and III). The pie charts represent the relative
percentage of fully unmethylated epialleles (U D white), fully methylated epialleles (M D black), and the 62 intermediate epialleles (I D gray gradient). The line plots rep-
resent the frequency distribution of each of the 62 intermediate epialleles (blue: undifferentiated ESC; red: differentiated ESCs). D) Comparison between average fre-
quency distribution of each of the 62 Ddo intermediate epialleles, from 3 independent experiments, in undifferentiated (blue line) vs. differentiated (red line) ESCs. The
speciﬁc methyl CpG combinations of each of the 62 intermediate epialleles are indicated on the x-axis.
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methylation establishment, changes and, potentially, alterations
of these processes that occur in neurodevelopmental diseases,
which may not be revealed by conventional analyses of (gene-
speciﬁc or genome-wide) average methylation.
Materials and methods
Animals
C57BL/6J mice were purchased from the Jackson Laboratory
(Bar Harbour, ME). In CE.IN.GE’s laboratories, mice were
housed in groups (n D 4 or 5) in standard cages
(29£17.5£12.5 cm) at constant temperature (22 § 1C) and
maintained on a 12/12 h light/dark cycle, with food and water
ad libitum. All research involving animals was performed in
accordance with the European directive 86/609/EEC governing
animal welfare and protection, which is acknowledged by the
Italian Legislative Decree no. 116 (January 27, 1992). Animal
research protocols were also reviewed and consented by a local
animal care committee. Whole brains were collected from mice
at different developmental stages, at time points E15, P0, P7,
P14, P21, P30, and P60. Five brain areas were dissected (pre-
frontal cortex, cortex, hippocampus, cerebellum, and striatum)
from 2 mice (P30). All tissue samples were pulverized in liquid
nitrogen and stored at ¡80C.
Cells
Primary Cortical Neurons. Cortical neurons were prepared
from brains of 17-day-old C57BL/6J mouse embryos, as previ-
ously described.33 Brieﬂy, mice were ﬁrst anesthetized and then
killed by cervical dislocation to minimize the animals’ pain and
distress. Dissection and dissociation were performed in Ca2/
Mg2-free buffer saline (HBSS). Tissues were incubated with
trypsin for 20 min at 37C and dissociated by trituration in cul-
ture medium. Cells were plated at 3.5–5£106 in 60 mm plastic
Petri dishes, precoated with poly-D-lysine (20 mg/ml), in
MEM/F12 (Invitrogen, Carlsbad, CA) containing glucose, 5%
deactivated FBS, and 5% horse serum (Invitrogen), glutamine,
and antibiotics. Ara-C (10 mM) was added within 48 h of plat-
ing to prevent non-neuronal cell growth. Neurons were cul-
tured at 37C in a humidiﬁed 5% CO2 atmosphere. All the
Figure 8. Epigenetic correlation of Ddo R4 epialleles distribution in ES and different puriﬁed brain-derived cell types performed by PCA. A) Scores plot represents the
distribution of each speciﬁc cell type (blue D neurons; pink D oligodendrocytes; green D microglial; violet D astrocytes; gray D U-ES undifferentiated ESCs, red D nD-ES
differentiated ESCs). The analysis was based on the qualitative and quantitative inﬂuence of each of the 64 epialleles displayed by each cell type. B) Loading plots of PCA.
The vectors represented by red arrows show how (the direction) and how much (the length) each epiallelic proﬁle contributes to the individual correlations represented
by PC1 and PC2. Note that each epiallele is named with numbers (1–62) or letters (U, F), as reported in Fig. 3B. C) The heatmaps show the contribution of each CpG in
different epiallelic classes among 4 cell types (U-ES D undifferentiated ESC; nD_ES D neuronal differentiated ESCs). The color scale from red to yellow (from low to high
values) shows the contribution of each CpG to formation of monomethylated (1M), dimethylated (2M), trimethylated (3M), tetramethylated (4M), pentamethylated (5M),
and fully methylated (6M) molecules, respectively.
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experiments on primary cortical neurons were performed
according to the procedures described in experimental proto-
cols approved by the Ethical Committee of the Federico II Uni-
versity of Naples.
Primary microglia, oligodendrocytes, and astrocytes
isolation from mixed glial cell cultures
Puriﬁed microglia, oligodendrocyte, and astrocyte cells were pre-
pared from primary mouse mixed glial cells as previously
described.34,35 Brieﬂy, cerebral cortices isolated from post-natal
day 1 mouse brain were ﬁrst dissociated enzymatically in a solu-
tion containing 0.125% trypsin and 1.5 mg/mL DNase (Sigma-
Aldrich, St. Louis, MO) and then mechanically in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% fetal bovine
serum, 1% penicillin-streptomycin, 2 mmol/L L-glutamine (Invi-
trogen). Cell pellet was resuspended and plated in tissue culture
ﬂasks in normal medium at 37C in a humidiﬁed, 5% CO2 incu-
bator. After 12–15 days, the microglia were separated by
mechanical shaking of ﬂasks on a orbital shaker for 60 min at
200 rpm at 37C. The suspension containing microglia was cen-
trifuged at 1000 rpm for 5 min and the pellet stored at ¡80C.
This procedure yielded 98% IB4- FITC or OX42-positive cells.
To isolate oligodendrocyte lineage cells, the cultures were then
subjected to an additional 16 h of shaking at 200 rpm. To mini-
mize contamination by microglial cells, the suspension of
detached cells was incubated twice for 40 minutes at room tem-
perature. The non-adhering oligodendrocytes were centrifuged at
1000 rpm for 5 min and the pellet stored at ¡80C. This proce-
dure yielded 98% NG2-positive cells. Finally, the remaining con-
ﬂuent astrocytes were washed, scraped, centrifuged, and the
pellets stored at ¡80C until further analysis. This procedure
yielded 98% GFAP-positive cells.
Embryonic stem cells
In vitro differentiation toward neurons and glia cells was per-
formed as previously described.36 Brieﬂy, at day 0, wild type
TBV (129/SvP) ESCs were dissociated in a single-cell suspen-
sion and 1000 cells/cm2 were plated on gelatin-coated plates.
The culture medium was replaced daily during differentiation
process.
Immortalized cells
A1 mes c-myc (A1) is a cell line immortalized by means of
infection with a c-myc-carrying retroviral vector of a primary
mouse mesencephalon derived cells culture prepared from 11-
day-old embryos (E11) as previously described.37 These cells
proliferate and remain undifferentiated when grown in MEM/
F12 (Invitrogen, Milan, Italy) supplemented with 10% FBS
(HyClone, Milan, Italy).
DNA extraction from cells and tissues
DNA was extracted from a portion of liquid nitrogen–pulver-
ized tissue or cell pellets. DNA was prepared using DNeasy
Blood & Tissue Kit (Qiagen, Hilden, Germany), following the
manufacturer’s instructions. DNA was quality checked by 260/
280 absorbance ratio using NanoDrop 2000, (Thermo Scien-
tiﬁc) and it was quantiﬁed using Qubit 2.0 Fluorometer with
the dsDNA broad range assay kit (Invitrogen, Q32850).
Bisulﬁte treatment and amplicon library preparation
Bisulﬁte treatment was performed using EZ DNA Methylation
Kit (Zymo Research). Genomic DNA (2 mg) was converted
with “C/T conversion reagent” and eluted in 50 ml of H2O fol-
lowing the manufacturer’s instruction. To evaluate the DNA
methylation levels, a double step PCR strategy was used to gen-
erate an amplicon library of bisulﬁte treated DNA that was
sequenced by Illumina Miseq Sequencer. In the ﬁrst PCR reac-
tion, we designed primers to generate tiled amplicons ranging
in size between 300–450 bp (all primers pairs are reported in
Table 1). The 50 end of these primers contains overhang adap-
tor sequences (FW: 50 TCGTCGGCAGCGTCAGATGTGTA-
TAAGAGACAG ‘3; RV: 50 GTCTCGTGGGCTCGGAGATGT
GTATAAGAGACAG ‘3) that must be used in the second step
of PCR to add multiplexing indices and Illumina sequencing
adaptors. To obtain ﬁrst PCR products we used the FastStart
High Fidelity PCR System (Roche) at the following thermo
cycle condition: one cycle at 95C for 2 min followed by 32
cycles at 95C for 30 s, [primer Tm] for 40 s, 72C for 50 s, fol-
lowed by a ﬁnal extension step at 72C for 6 min. Reactions
were performed in 30 ml total volumes: 3 ml 10x reaction
buffer, 0.6 ml of 10 mM dNTP mix, 0.9 ml of 5 mM forward
and reverse primers, 3.6 ml MgCl2 25 mM, 2–4 ml bisulﬁte tem-
plate DNA, 0.25 ml FastStart Taq, and H2O up to a ﬁnal volume
of 30 ml. To eliminate small DNA fragments (primers dimers),
we used AMPure puriﬁcation magnetic Beads (Beckman-Coul-
ter, Brea, CA) following the manufacturer’s protocol. The ratio
between AMPure Beads volume and PCR products volume was
0.8. Product size was checked on 1.5% agarose gel. Second PCR
step was performed in 50 ml total volumes: 5 ml 10x reaction
buffer, 1 ml dNTP mix, 5 ml forward and reverse “Nextera XT”
primers (Illumina, San Diego, CA), 6 ml 25 mM MgCl2, 5 ml of
ﬁrst PCR product, 0.4 ml FastStart Taq, and H2O up to a ﬁnal
volume of 50 ml. Thermocycler settings were: one cycle at 95C
for 2 min followed by 8 cycles at 95C 30 s, 55C for 40 s, 72C
for 40 s, followed by a ﬁnal extension step at 72C for 5 min.
Another puriﬁcation step by AMPure Beads was performed
and all amplicons were quantiﬁed using Qubit 2.0 Fluorome-
ter. The quality of each amplicon was checked by Agilent 2100
Bioanalyzer using the DNA 1000 Kit (Agilent Technologies,
Santa Clara, CA), according to the manufacturer’s instructions.
Amplicons were pooled at equimolar ratio and then diluted to
ﬁnal concentration of 8 picomolar. Phix control libraries (Illu-
mina) were combined with normalized library [15% (v/v)] to
increase diversity of base calling during sequencing. Amplicons
library was subjected to sequencing using V3 reagents kits on
Illumina MiSeq system (Illumina). Paired-end sequencing was
performed in 281 cycles per read (281£2). An average of
210,000 reads/sample were used for further analysis. The rate
of bisulﬁte conversion was estimated as 98–99%, as calculated
by spike-in experiments performed by adding fully unmethy-
lated M13mp18 double strand DNA (New England BioLabs) in
10 representative samples (primers pairs are reported in
Table 1).
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Sequence handling
First, paired-end reads obtained from Illumina Miseq
sequencer platform were merged together using PEAR
tool38 with a minimum of 40 overlapping residues as
threshold and quality ﬁltered was obtained using as thresh-
old a mean PHREAD score of at least 33. FASTQ assem-
bled reads were converted to FASTA format using
PRINSEQ tool.39 To analyze the methylation status of each
amplicon, we used our pipeline software (Amplimethpro-
ﬁler), freely available at https://sourceforge.net/projects/
amplimethproﬁler. This tool is speciﬁcally designed for deep
targeted bisulﬁte amplicon sequencing of multiple genomic
regions and provides functions to demultiplex, ﬁlter and extract
methylation proﬁles directly from FASTA ﬁles. All the ﬁlters
(read length, percent of similarity between end of the read and
the sequence primer, bisulﬁte efﬁciency, maximum percentage
of ambiguously aligned CG sites, percent of aligned read) may
be tuned by user speciﬁed threshold. In the ﬁrst step, Ampli-
methproﬁler generates, for each sequenced region a quality ﬁl-
tered FASTA ﬁle, whose entries are annotated with the ID of
the region and of the sample, then discarding reads that do not
match expected length (possibly derived from dimers and/or
other artifacts). Next, reads are aligned to the corresponding
bisulphite converted reference using BLASTn.40 As output, the
pipeline returns: i) a summary and quality statistics ﬁle, con-
taining information about the number of reads that pass ﬁlter-
ing, the methylation percentage of each C in CpG sites, and the
bisulﬁte efﬁciency for each C in non-CpG sites; ii) an alignment
ﬁle where the bisulﬁte efﬁciency/read is calculated; iii) a CpG
methylation proﬁles ﬁle, containing a matrix that reports the
methylation status for each CpG dinucleotide: 0 if the site is
recognized as unmethylated, 1 if the site is recognized as meth-
ylated, and 2 if the methylation state could not be assessed.
Each row of the matrix can be considered as the CpG methyla-
tion proﬁle and deﬁnes an epiallele in subsequent analyses.
Then, we used this output to perform downstream analyses.
Quantitative methylation averages for each site are then com-
puted as the number of non-converted bases mapped on that
site over the total number of mapped reads. Single molecule
CpG methylation arrangement was then performed. Based on
R software (R Core Team, 2016, https://www.R-project.org),
the abundance of each one of the 2NCpG distinct
epialleles (where NCpG stands for the number of CpG sites in
the analyzed region) was evaluated for each sample by
counting the number of passing ﬁlter reads containing that epi-
allele. Filter was set in order to include only reads with the
expected lenght and containing no more that 2% unconverted
cytosine outside CpG sites. The number of total reads and the
reads used for epiallele analyses are reported in supplemental
Table S1.
Statistical analysis
Methylation average data are expressed as means § stan-
dard deviation. Comparisons between 2 groups were per-
formed using the unpaired Student t test. Multiple
comparisons were made by 1-way ANOVA followed by
Tukey post-hoc test. A P-value  0.05 was considered sta-
tistically signiﬁcant. Pearson correlation test was used to
assess the relationship among the epialleles distribution
within each stages group. PCA was performed on the abun-
dance of each 64 epialleles presents in the analyzed cell
population. PC1 explained 31.2% and PC2 explained 29%
of the observed variance. All statistical analyses were per-
formed using JMP software (SAS, Cary, NC).
Availability of data: Accession Numbers
The data sets generated during the current study are deposited
on “European Nucleotide Archive (ENA)” server, www.ebi.ac.
uk/ena, under the accession number PRJEB16320.
Disclosure of potential conﬂicts of interest
No potential conﬂicts of interest were disclosed.
Funding
This work was supported by grant from Epigenomics Flagship Projects
—EPIGEN, C.N.R to LC, VEA and GaM and from NARSAD Young inves-
tigator grant 2015 to FE.
References
1. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. Decoding the epige-
netic language of neuronal plasticity. Neuron 2008; 60:961-74;
PMID:19109904; http://dx.doi.org/10.1016/j.neuron.2008.10.012
2. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M,
Colantuoni C, Weinberger DR, Kleinman JE, Lipska BK. DNA meth-
ylation signatures in development and aging of the human prefrontal
cortex. Am J Hum Genet 2012; 90:260-72; PMID:22305529; http://dx.
doi.org/10.1016/j.ajhg.2011.12.020
3. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson
ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, et al. Global epi-
genomic reconﬁguration during mammalian brain development.
Science 2013; 341:1237905; PMID:23828890; http://dx.doi.org/
10.1126/science.1237905
4. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyl-
transferase gene results in embryonic lethality. Cell 1992; 69:915-26;
PMID:1606615; http://dx.doi.org/10.1016/0092-8674(92)90611-F
5. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases
Dnmt3a and Dnmt3b are essential for de novo methylation and mam-
malian development. Cell 1999; 99:247-57; PMID:10555141; http://dx.
doi.org/10.1016/S0092-8674(00)81656-6
6. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales
FA, Jones PA. The human DNA methyltransferases (DNMTs) 1, 3a
and 3b: coordinate mRNA expression in normal tissues and overex-
pression in tumors. Nucleic Acids Res 1999; 27:2291-8;
PMID:10325416; http://dx.doi.org/10.1093/nar/27.11.2291
7. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian
development. Science 2001; 293:1089-93; PMID:11498579; http://dx.
doi.org/10.1126/science.1063443
8. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethyl-
cytosine is present in Purkinje neurons and the brain. Science
2009; 324:929-30; PMID:19372393; http://dx.doi.org/10.1126/
science.1169786
9. Mo A, Mukamel EA, Davis FP, Luo C, Henry GL, Picard S, Urich MA,
Nery JR, Sejnowski TJ, Lister R, et al. Epigenomic Signatures of Neu-
ronal Diversity in the Mammalian Brain. Neuron 2015; 86:1369-84;
PMID:26087164; http://dx.doi.org/10.1016/j.neuron.2015.05.018
EPIGENETICS 53
D
ow
nl
oa
de
d 
by
 [T
am
pe
re 
Un
ive
rsi
ty]
 at
 23
:01
 03
 D
ec
em
be
r 2
01
7 
10. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation
in psychiatric disorders. Nat Rev Neurosci 2007; 8:355-67;
PMID:17453016; http://dx.doi.org/10.1038/nrn2132
11. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia
P, Assadzadeh A, Flanagan J, Schumacher A, et al. Epigenomic proﬁl-
ing reveals DNA-methylation changes associated with major psycho-
sis. Am J Hum Genet 2008; 82:696-711; PMID:18319075; http://dx.
doi.org/10.1016/j.ajhg.2008.01.008
12. Miller G. Epigenetics. The seductive allure of behavioral epigenetics.
Science 2010; 329:24-7; PMID:20595592; http://dx.doi.org/10.1126/
science.329.5987.24
13. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, Sac-
chetti S, Lembo F, Angiolillo A, Jovanovic N, et al. Increased BDNF
promoter methylation in the Wernicke area of suicide subjects. Arch
Gen Psychiatry 2010; 67:258-67; PMID:20194826; http://dx.doi.org/
10.1001/archgenpsychiatry.2010.9
14. Keller S, Sarchiapone M, Zarrilli F, Tomaiuolo R, Carli V, Angrisano
T, Videtic A, Amato F, Pero R, di Giannantonio M, et al. TrkB gene
expression and DNA methylation state in Wernicke area does not
associate with suicidal behavior. J Affect Disord 2011; 135:400-4;
PMID:21802740; http://dx.doi.org/10.1016/j.jad.2011.07.003
15. Keller S, Errico F, Zarrilli F, Florio E, Punzo D, Mansueto S, Angri-
sano T, Pero R, Lembo F, Castaldo G, et al. DNA methylation state of
BDNF gene is not altered in prefrontal cortex and striatum of schizo-
phrenia subjects. Psychiatry Res 2014; 220:1147-50; PMID:25219617;
http://dx.doi.org/10.1016/j.psychres.2014.08.022
16. Akbarian S, Nestler EJ. Epigenetic mechanisms in psychiatry. Neuro-
psychopharmacology 2013; 38:1-2; PMID:23147478; http://dx.doi.org/
10.1038/npp.2012.185
17. Perroud N, Salzmann A, Prada P, Nicastro R, Hoeppli ME, Furrer S,
Ardu S, Krejci I, Karege F, Malafosse A. Response to psychotherapy in
borderline personality disorder and methylation status of the BDNF
gene. Transl Psychiatry 2013; 3:e207; PMID:23422958; http://dx.doi.
org/10.1038/tp.2012.140
18. Labonte B, Suderman M, Maussion G, Navaro L, Yerko V, Mahar I,
Bureau A, Mechawar N, Szyf M, Meaney MJ, et al. Genome-wide epi-
genetic regulation by early-life trauma. Arch Gen Psychiatry 2012;
69:722-31; PMID:22752237
19. Lutz PE, Almeida D, Fiori LM, Turecki G. Childhood maltreatment
and stress-related psychopathology: the epigenetic memory hypothe-
sis. Curr Pharm Des 2015; 21:1413-7; PMID:25564388; http://dx.doi.
org/10.2174/1381612821666150105124928
20. Nestler EJ, Pe~na CJ, Kundakovic M, Mitchell A, Akbarian S. Epige-
netic basis of mental Illness. Neuroscientist 2015; 22(5):447-63;
pii:1073858415608147; PMID:26450593; http://dx.doi.org/10.1177/
1073858415608147
21. Qu W, Tsukahara T, Nakamura R, Yurino H, Hashimoto S, Tsuji S,
Takeda H, Morishita S. Assessing Cell-to-Cell DNA Methylation vari-
ability on individual long reads. Sci Rep 2016; 6:21317;
PMID:26888466; http://dx.doi.org/10.1038/srep21317
22. Li S, Garrett-Bakelman F, Perl AE, Luger SM, Zhang C, To BL, Lewis
ID, Brown AL, D’Andrea RJ, Ross ME, et al. Dynamic evolution of
clonal epialleles revealed by methclone. Genome Biol 2014; 15:472;
PMID:25260792; http://dx.doi.org/10.1186/s13059-014-0472-5
23. Landan G, Cohen NM, Mukamel Z, Bar A, Molchadsky A, Brosh R,
Horn-Saban S, Zalcenstein DA, Goldﬁnger N, Zundelevich A, et al.
Epigenetic polymorphism and the stochastic formation of differen-
tially methylated regions in normal and cancerous tissues. Nat Genet
2012; 44:1207-14; PMID:23064413; http://dx.doi.org/10.1038/ng.2442
24. Errico F, D’Argenio V, Sforazzini F, Iasevoli F, Squillace M, Guerri G,
Napolitano F, Angrisano T, Di Maio A, Keller S, et al. A role for D-
aspartate oxidase in schizophrenia and in schizophrenia-related symp-
toms induced by phencyclidine in mice. Transl Psychiatry 2015; 5:
e512; PMID:25689573; http://dx.doi.org/10.1038/tp.2015.2
25. Punzo D, Errico F, Cristino L, Sacchi S, Keller S, Belardo C, Luongo L,
Nuzzo T, Imperatore R, Florio E, et al. Age-Related changes in d-
Aspartate oxidase promoter methylation control extracellular d-
Aspartate levels and prevent precocious cell death during brain aging.
J Neurosci 2016; 36:3064-78; PMID:26961959; http://dx.doi.org/
10.1523/JNEUROSCI.3881-15.2016
26. McGowan PO Szyf M. The epigenetics of social adversity in early life:
implications for mental health outcomes. Neurobiol Dis 2010; 39:66-
72; PMID:20053376; http://dx.doi.org/10.1016/j.nbd.2009.12.026
27. Mikeska T, Candiloro IL, Dobrovic A. The implications of heteroge-
neous DNA methylation for the accurate quantiﬁcation of methyla-
tion. Epigenomics 2010; 2:561-73; PMID:22121974; http://dx.doi.org/
10.2217/epi.10.32
28. Candiloro IL, Mikeska T, Dobrovic A. Assessing combined methyla-
tion-sensitive high resolution melting and pyrosequencing for the
analysis of heterogeneous DNA methylation. Epigenetics 2011; 6:500-
7; PMID:21364322; http://dx.doi.org/10.4161/epi.6.4.14853
29. Li S, Garrett-Bakelman FE, Chung SS, Sanders MA, Hricik T, Rapa-
port F, Patel J, Dillon R, Vijay P, Brown AL, et al. Distinct evolution
and dynamics of epigenetic and genetic heterogeneity in acute mye-
loid leukemia. Nat Med 2016; 22(7):792-9; PMID:27322744; http://dx.
doi.org/10.1038/nm.4125
30. Wee EJ, Rauf S, Shiddiky MJ, Dobrovic A, Trau M. DNA ligase-based
strategy for quantifying heterogeneous DNA methylation without
sequencing. Clin Chem 2015; 61:163-71; PMID:25274555; http://dx.
doi.org/10.1373/clinchem.2014.227546
31. Gravina S, Dong X, Yu B, Vijg J. Single-cell genome-wide bisulﬁte
sequencing uncovers extensive heterogeneity in the mouse liver meth-
ylome. Genome Biol 2016; 17:150; PMID:27380908; http://dx.doi.org/
10.1186/s13059-016-1011-3
32. Angermueller C, Clark SJ, Lee HJ, Macaulay IC, TengMJ, Hu TX, Krueger
F, Smallwood SA, Ponting CP, Voet T, et al. Parallel single-cell sequencing
links transcriptional and epigenetic heterogeneity. Nat Methods 2016;
13:229-32; PMID:26752769; http://dx.doi.org/10.1038/nmeth.3728
33. Sisalli MJ, Secondo A, Esposito A, Valsecchi V, Savoia C, Di Renzo
GF, Annunziato L, Scorziello A. Endoplasmic reticulum reﬁlling and
mitochondrial calcium extrusion promoted in neurons by NCX1 and
NCX3 in ischemic preconditioning are determinant for neuroprotec-
tion. Cell Death Differ 2014; 21:1142-9; PMID:24632945; http://dx.
doi.org/10.1038/cdd.2014.32
34. Boscia F, D’Avanzo C, Pannaccione A, Secondo A, Casamassa A, For-
misano L, Guida N, Sokolow S, Herchuelz A, Annunziato L. Silencing
or knocking out the Na(C)/Ca(2C) exchanger-3 (NCX3) impairs oli-
godendrocyte differentiation. Cell Death Differ 2012; 19:562-72;
PMID:21959935; http://dx.doi.org/10.1038/cdd.2011.125
35. Boscia F, Esposito CL, Casamassa A, de Franciscis V, Annunziato L,
Cerchia L. The isolectin IB4 binds RET receptor tyrosine kinase in
microglia. J Neurochem 2013; 126:428-36; PMID:23413818; http://dx.
doi.org/10.1111/jnc.12209
36. Fico A, Manganelli G, Simeone M, Guido S, Minchiotti G, Filosa
S. High-throughput screening-compatible single-step protocol to
differentiate embryonic stem cells in neurons. Stem Cells Dev
2008; 17:573-84; PMID:18576914; http://dx.doi.org/10.1089/scd.
2007.0130
37. Colucci-D’Amato GL, Tino A, Pernas-Alonso R, ffrench-Mullen JM,
di Porzio U. Neuronal and glial properties coexist in a novel mouse
CNS immortalized cell line. Exp Cell Res 1999; 252:383-91;
PMID:10527628; http://dx.doi.org/10.1006/excr.1999.4636
38. Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate
Illumina Paired-End reAd mergeR. Bioinformatics 2013; 30:614-20;
PMID:24142950; http://dx.doi.org/10.1093/bioinformatics/btt593
39. Schmieder R, Edwards R. Quality control and preprocessing of meta-
genomic datasets. Bioinformatics 2011; 27:863-4; PMID:21278185;
http://dx.doi.org/10.1093/bioinformatics/btr026
40. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer
K, Madden TL. BLASTC: architecture and applications. BMC Bioin-
formatics 2009; 10:421; PMID:20003500; http://dx.doi.org/10.1186/
1471-2105-10-421
54 E. FLORIO ET AL.
D
ow
nl
oa
de
d 
by
 [T
am
pe
re 
Un
ive
rsi
ty]
 at
 23
:01
 03
 D
ec
em
be
r 2
01
7 
